Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert F Rea

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Circulation. Arrhythmia and Electrophysiology|October 8, 2009
Mechanisms and utility of discrete great arterial potentials in the ablation of outflow tract ventricular arrhythmiasKomandoor S Srivathsan, T Jared Bunch, Samuel J Asirvatham, et al.
Pacing and Clinical Electrophysiology : PACE|March 18, 2011
No increased bleeding events with continuation of oral anticoagulation therapy for patients undergoing cardiac device procedureHung-Kei Li, Frank C Chen, Robert F Rea, et al.
Circulation. Heart Failure|March 23, 2011
Cardiac sympathetic reserve and response to cardiac resynchronization therapyYong-Mei Cha, Panithaya Chareonthaitawee, Ying-Xue Dong, et al.
Heart Rhythm|January 19, 2019
Stroke in patients with cardiovascular implantable electronic device infection undergoing transvenous lead removalJustin Z Lee, Pradyumna Agasthi, Ahmed K Pasha, et al.
The Journal of Clinical Investigation|June 12, 2020
Early safety indicators of COVID-19 convalescent plasma in 5000 patientsMichael J Joyner, R Scott Wright, DeLisa Fairweather, et al.
Medrxiv : the Preprint Server for Health Sciences|August 21, 2020
Effect of Convalescent Plasma on Mortality among Hospitalized Patients with COVID-19: Initial Three-Month ExperienceMichael J Joyner, Jonathon W Senefeld, Stephen A Klassen, et al.
Medrxiv : the Preprint Server for Health Sciences|April 14, 2021
Program and patient characteristics for the United States Expanded Access Program to COVID-19 convalescent plasmaJonathon W Senefeld, Patrick W Johnson, Katie L Kunze, et al.
The New England Journal of Medicine|February 1, 2021
Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19Michael J Joyner, Rickey E Carter, Jonathon W Senefeld, et al.
Mayo Clinic Proceedings|August 31, 2020
Safety Update: COVID-19 Convalescent Plasma in 20,000 Hospitalized PatientsMichael J Joyner, Katelyn A Bruno, Stephen A Klassen, et al.
Nature Communications|August 12, 2021
Mortality in individuals treated with COVID-19 convalescent plasma varies with the geographic provenance of donorsKatie L Kunze, Patrick W Johnson, Noud van Helmond, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Circulation. Arrhythmia and Electrophysiology|October 8, 2009
Mechanisms and utility of discrete great arterial potentials in the ablation of outflow tract ventricular arrhythmiasKomandoor S Srivathsan, T Jared Bunch, Samuel J Asirvatham, et al.
Pacing and Clinical Electrophysiology : PACE|March 18, 2011
No increased bleeding events with continuation of oral anticoagulation therapy for patients undergoing cardiac device procedureHung-Kei Li, Frank C Chen, Robert F Rea, et al.
Circulation. Heart Failure|March 23, 2011
Cardiac sympathetic reserve and response to cardiac resynchronization therapyYong-Mei Cha, Panithaya Chareonthaitawee, Ying-Xue Dong, et al.
Heart Rhythm|January 19, 2019
Stroke in patients with cardiovascular implantable electronic device infection undergoing transvenous lead removalJustin Z Lee, Pradyumna Agasthi, Ahmed K Pasha, et al.
The Journal of Clinical Investigation|June 12, 2020
Early safety indicators of COVID-19 convalescent plasma in 5000 patientsMichael J Joyner, R Scott Wright, DeLisa Fairweather, et al.
Medrxiv : the Preprint Server for Health Sciences|August 21, 2020
Effect of Convalescent Plasma on Mortality among Hospitalized Patients with COVID-19: Initial Three-Month ExperienceMichael J Joyner, Jonathon W Senefeld, Stephen A Klassen, et al.
Medrxiv : the Preprint Server for Health Sciences|April 14, 2021
Program and patient characteristics for the United States Expanded Access Program to COVID-19 convalescent plasmaJonathon W Senefeld, Patrick W Johnson, Katie L Kunze, et al.
The New England Journal of Medicine|February 1, 2021
Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19Michael J Joyner, Rickey E Carter, Jonathon W Senefeld, et al.
Mayo Clinic Proceedings|August 31, 2020
Safety Update: COVID-19 Convalescent Plasma in 20,000 Hospitalized PatientsMichael J Joyner, Katelyn A Bruno, Stephen A Klassen, et al.
Nature Communications|August 12, 2021
Mortality in individuals treated with COVID-19 convalescent plasma varies with the geographic provenance of donorsKatie L Kunze, Patrick W Johnson, Noud van Helmond, et al.
Pageof 6